Steadfast Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,096,590
Closed -$118M 113
2025
Q2
$118M Sell
1,096,590
-465,056
-30% -$47.1M 2.1% 17
2025
Q1
$158M Sell
1,561,646
-816,418
-34% -$82.2M 4.19% 6
2024
Q4
$212M Buy
2,378,064
+448,879
+23% +$39.5M 4.32% 3
2024
Q3
$162M Sell
1,929,185
-230,897
-11% -$18.2M 3.59% 6
2024
Q2
$166M Sell
2,160,082
-153,357
-7% -$11.2M 3.5% 10
2024
Q1
$158M Sell
2,313,439
-722,600
-24% -$46.5M 3.57% 8
2023
Q4
$176M Buy
3,036,039
+314,000
+12% +$16.8M 4.33% 5
2023
Q3
$144M Buy
2,722,039
+637,085
+31% +$33.4M 3.86% 6
2023
Q2
$113M Buy
2,084,954
+451,029
+28% +$23.6M 3% 13
2023
Q1
$81.7M Sell
1,633,925
-1,369,511
-46% -$64.5M 2.46% 16
2022
Q4
$139M Buy
+3,003,436
New +$130M 4.78% 8
2022
Q2
Sell
-1,710,408
Closed -$75.8M 48
2022
Q1
$75.8M Buy
+1,710,408
New +$74.1M 1.3% 21
2020
Q4
Sell
-9,475,750
Closed -$362M 59
2020
Q3
$362M Buy
9,475,750
+216,188
+2% +$8.33M 3.96% 4
2020
Q2
$325M Buy
9,259,562
+5,241,282
+130% +$189M 3.71% 7
2020
Q1
$131M Buy
+4,018,280
New +$157M 2.01% 21

Other funds holding BSX

Steadfast Capital Management's BSX Position: Q3 2025 in Review

Steadfast Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 1,096,590 shares — an estimated $118M sold.

Steadfast Capital Management first reported a position in BSX in Q1 2020 and held it in 15 quarters. The position peaked at $362M in Q3 2020. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Steadfast Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Steadfast Capital Management sold 1,096,590 Boston Scientific shares in Q3 2025, an estimated $118M.
  • Steadfast Capital Management first reported a position in Boston Scientific in Q1 2020 and held it in 15 quarters.
  • Steadfast Capital Management's Boston Scientific position peaked at $362M in Q3 2020.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Steadfast Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.